Eisai receives approval from European Commission for indication expansion of Halaven
Eisai receives approval from European Commission for indication expansion of Halaven
About this item
Full title
Eisai receives approval from European Commission for indication expansion of Halaven
Publisher
London: Normans Media Ltd
Journal title
M2 Pharma, 2014
Language
English
Formats
Publication information
Publisher
London: Normans Media Ltd
Subjects
More information
Scope and Contents
Contents
M2PHARMA-July 8, 2014-Eisai receives approval from European Commission for indication expansion of Halaven (C)2014 M2 COMMUNICATIONS http://www.m2.com Eisai, a Japan-based pharmaceutical company, has received approval from the European Commission for the indication expansion of Halaven (eribulin mesyl...
Alternative Titles
Full title
Eisai receives approval from European Commission for indication expansion of Halaven
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1543418480
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1543418480
How to access this item
Log in as a Library member
